Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-11

Clinical Trial Update: Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports tolerability findings for three local anesthetic formulations used with NGX-4010 (capsaicin 8% patch) in the treatment of neuropa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Herpes Zoster, Neuralgia | Phase 2 | Status: COMPLETED